Molly J. DeCristo

2.6k citations
10 papers · 1.7k indexed · 2 hit papers · h-index 8

Molly J. DeCristo

10 papers receiving 1.7k citations

Hit Papers

CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest3322017202620202023250500750

Peers

Molly J. DeCristo
Comparison fields: 5 of 79
  • Oncology 1.1k
  • Immunology 456
  • Pulmonary and Respiratory Medicine 675
  • Cancer Research 288
  • Genetics 168
Replace Yongping Song with:
Yongping Song China
Joan T. Garrett United States
Neil E. Bhola United States
Silvestre Vicent Spain
Umesh Bhanot United States
Bisrat G. Debeb United States
Patrick G. Pilié United States
Alan T. Yeo United States
Siyuan Weng China
Simona Ruggieri Italy
Molly J. DeCristo relative to Yongping Song China Yongping Song's profile →
Citations per field
00.5×1.5×
Yongping Song · 1×
Citations per year

Countries citing papers authored by Molly J. DeCristo

Since Specialization
Citations

This map shows the geographic impact of Molly J. DeCristo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly J. DeCristo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly J. DeCristo more than expected).

Fields of papers citing papers by Molly J. DeCristo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly J. DeCristo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly J. DeCristo. The network helps show where Molly J. DeCristo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Molly J. DeCristo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Molly J. DeCristo Line = papers co-authored together Molly J. DeCristo links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 2019110
2 201823
3 2018130
4 20187
5
CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrestbreakdown →
2018332
6
CDK4/6 inhibition triggers anti-tumour immunitybreakdown →
2017998
7 201729
8 201431
9 201353
10 20131

About Molly J. DeCristo

Molly J. DeCristo is a scholar working on Oncology, Genetics and Orthopedics and Sports Medicine, having authored 10 papers that have together received 1.7k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Advanced Breast Cancer Therapies (2 papers), Bone health and treatments (2 papers), Immunotherapy and Immune Responses (2 papers), Cancer-related Molecular Pathways (2 papers), Cancer Cells and Metastasis (2 papers) and Bone and Joint Diseases (1 paper). The work is most often cited by research in Oncology (1.1k citations), Immunology (456 citations) and Pulmonary and Respiratory Medicine (675 citations). Molly J. DeCristo has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Sandra S. McAllister, Jean J. Zhao, Shom Goel, Jessalyn M. Ubellacker, Jaclyn Sceneay, Eric P. Winer, Thomas M. Roberts, April C. Watt, Naveed Khan and Susanne Ramm. Their work appears in journals such as Nature Cell Biology, Genes & Cancer, Trends in Cell Biology, Nature and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026